SBIA
BIAF icon

Sheaff Brock Investment Advisors’s bioAffinity Technologies BIAF Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$14K Buy
119
+16
+16% +$4.4K ﹤0.01% 456
2024
Q4 		$42.1K Buy
103
+59
+134% +$35.6K ﹤0.01% 447
2024
Q3 		$41.6K Buy
44
+11
+33% +$9.89K ﹤0.01% 450
2024
Q2 		$32.4K Buy
33
+11
+50% +$11.4K ﹤0.01% 445
2024
Q1 		$20.2K Buy
+22
New +$17.2K ﹤0.01% 506

Other funds holding BIAF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VHAM
Van Hulzen Asset Management El Dorado Hills, California $1.41B AUM 27.05% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Sheaff Brock Investment Advisors's BIAF Position: Q1 2025 in Review

Sheaff Brock Investment Advisors increased its bioAffinity Technologies (BIAF) stake by 16% in Q1 2025, buying an estimated $4.4K and bringing the position to 119 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Sheaff Brock Investment Advisors first reported a position in BIAF in Q1 2024 and has held it in 5 quarters since. The position peaked at $42.1K in Q4 2024. 15 funds tracked by Wall St. Rank hold BIAF as of Q1 2025.

  • Sheaff Brock Investment Advisors held 119 shares of bioAffinity Technologies worth $14K as of Q1 2025.
  • Sheaff Brock Investment Advisors bought 16 bioAffinity Technologies shares in Q1 2025, an estimated $4.4K.
  • bioAffinity Technologies made up ﹤0.01% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #456 holding.
  • Sheaff Brock Investment Advisors first reported a position in bioAffinity Technologies in Q1 2024 and has held it in 5 quarters since.
  • Sheaff Brock Investment Advisors's bioAffinity Technologies position peaked at $42.1K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.